BIOFRONTERA |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.298 EUR | -12.87% |
|
-4.49% | -27.32% |
| 05-15 | Earnings Flash (BFRI) BIOFRONTERA Reports Q1 Revenue $7.9M, vs. Street Est of $10.9M | MT |
| 04-30 | Biofrontera AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar Biofrontera
e7.wX2oEgboggYdyBMOm9dZGW4bwrc_tCTiZGHzptZDj4A.iEnnQX6_3WNXg1xb0JYpYTZSiOZ3gWiNMg626ZUKxbfyHvhDNqLyUn_xKw~8d61aa94ef892aced74b5b8b87a88d42
Past events on Biofrontera
| 28/05/2024 | Q1 2024 Earnings Release (Projected) |
| 13/05/2024 | Reverse Split: 1 of 21; Rights Issue: 1 new share @ 1.1 EUR of 1 existing share |
| 13/05/2024 | Rights Issue: 1 new share @ 1.1 EUR for 1 existing share |
| 31/08/2023 09:00 | Q2 2023 Earnings Release |
| 20/06/2023 10:30 | Annual General Meeting |
| 31/05/2023 13:00 | Q1 2023 Earnings Call |
| 31/05/2023 10:30 | Q1 2023 Earnings Release |
| 27/04/2023 22:20 | Q4 2022 Earnings Release |
| 22/11/2022 | Q3 2022 Earnings Release |
| 27/10/2022 | Rights Issue: 1 new share @ 1 EUR for 8 existing shares |
| 23/08/2022 10:00 | Annual General Meeting |
| 17/08/2022 | Interim 2022 Earnings Release |
| 19/05/2022 13:00 | Q1 2022 Earnings Call |
| 17/05/2022 15:20 | Q1 2022 Earnings Release |
| 02/05/2022 13:00 | FY 2021 Earnings Call |
| 27/04/2022 | FY 2021 Earnings Release |
| 14/12/2021 09:00 | Annual General Meeting |
| 21/11/2021 | Analyst Conference |
| 18/11/2021 13:00 | Q3 2021 Earnings Call |
| 17/11/2021 22:00 | Q3 2021 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 31,3 31,3 0.05% | 30,3 30,3 0.04% | 28,8 28,9 -0.22% | 25,7 27,0 -4.67% |
|
EBITDA Million EUR | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -32,1 -31,2 -2.73% | 1,87 3,90 -52.08% |
|
EBIT Million EUR | Released Forecast Spread | -23,4 -23,8 1.64% | -7,61 -9,43 19.32% | -35,3 -35,4 0.17% | 1,12 3,10 -63.74% |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -4,78 -5,25 9.01% | -12,7 -12,8 0.8% | 35,7 -37,8 194.52% | -43,2 -42,1 -2.64% |
|
Net income Million EUR | Released Forecast Spread | -7,36 -5,25 -40.15% | -13,0 -13,1 0.33% | 38,3 -32,1 219.37% | -44,2 -42,1 -4.91% |
|
EPS EUR | Released Forecast Spread | -3,36 -2,52 -33.33% | -5,04 -5,78 12.73% | 14,3 -9,66 247.83% | -16,2 -12,4 -30.51% |
| Announcement Date | 20/04/20 | 12/04/21 | 30/04/22 | 28/04/23 |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 |
|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 10,3 10,4 -0.83% | 6,57 9,70 -32.31% | 8,51 10,4 -18.17% |
|
EBIT Million EUR | Released Forecast Spread | -22,8 -22,8 0.14% | 1,15 | |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 50,3 -23,3 315.93% | -28,1 -5,10 -450.98% | -7,96 -5,40 -47.43% |
|
Net income Million EUR | Released Forecast Spread | 53,0 -23,3 327.42% | -28,1 -5,10 -450.98% | -8,65 -5,40 -60.09% |
| Announcement Date | 30/04/22 | 17/05/22 | 19/08/22 |
More events
Past sector events for Biofrontera
| 30/05/2024 13:08 | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 30/05/2024 12:00 | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
| 30/05/2024 07:24 | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
| 29/05/2024 13:00 | FDC LIMITED: Q4 2024 Earnings Release |
| 29/05/2024 10:26 | JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release |
| 29/05/2024 09:44 | ALKEM LABORATORIES LIMITED: Q4 2024 Earnings Release |
| 29/05/2024 09:10 | IPCA LABORATORIES LIMITED: Q4 2024 Earnings Release |
| 28/05/2024 | PFIZER LIMITED: Q4 2024 Earnings Release |
| 27/05/2024 | DOTTIKON ES HOLDING AG: Q4 2024 Earnings Release |
| 27/05/2024 13:10 | ASTRAZENECA PHARMA INDIA LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- B8FK Stock
- B8F Stock
- Calendar Biofrontera
